Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9528 |
High Similarity |
NPD4908 |
Phase 1 |
0.938 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8976 |
High Similarity |
NPD1610 |
Phase 2 |
0.8516 |
High Similarity |
NPD1548 |
Phase 1 |
0.8333 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.8296 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.8276 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.8271 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8261 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8175 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8146 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8116 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8102 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8029 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7943 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7885 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7877 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7721 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7667 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7625 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7603 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7603 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7597 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7582 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7568 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD8651 |
Approved |
0.755 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7464 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7463 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7436 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7425 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7425 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7419 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7402 |
Intermediate Similarity |
NPD940 |
Approved |
0.7402 |
Intermediate Similarity |
NPD846 |
Approved |
0.74 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7389 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7378 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7368 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7358 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7347 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7347 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7333 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7328 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7319 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7319 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD968 |
Approved |
0.7297 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7297 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD7037 |
Approved |
0.726 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7252 |
Intermediate Similarity |
NPD290 |
Approved |
0.7244 |
Intermediate Similarity |
NPD3020 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7234 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7229 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7212 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7212 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7211 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7185 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7183 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7181 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7174 |
Intermediate Similarity |
NPD6581 |
Approved |
0.7174 |
Intermediate Similarity |
NPD6580 |
Approved |
0.717 |
Intermediate Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7162 |
Intermediate Similarity |
NPD1607 |
Approved |
0.716 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7126 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7123 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD6830 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD7119 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD37 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD7030 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7773 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7078 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7078 |
Intermediate Similarity |
NPD6815 |
Approved |
0.7075 |
Intermediate Similarity |
NPD7265 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7059 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7059 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7054 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.705 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7047 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7042 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7042 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7008 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7008 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3445 |
Approved |
0.7 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD3444 |
Approved |
0.7 |
Intermediate Similarity |
NPD3443 |
Approved |
0.7 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6987 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD821 |
Approved |
0.6981 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6975 |
Remote Similarity |
NPD3882 |
Suspended |
0.6974 |
Remote Similarity |
NPD5762 |
Approved |
0.6974 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD5763 |
Approved |
0.6974 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6966 |
Remote Similarity |
NPD3691 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD3690 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD7477 |
Discontinued |
0.6957 |
Remote Similarity |
NPD2557 |
Approved |
0.695 |
Remote Similarity |
NPD2667 |
Approved |
0.695 |
Remote Similarity |
NPD2668 |
Approved |
0.6944 |
Remote Similarity |
NPD6696 |
Suspended |
0.6943
|
Remote Similarity |
NPD1512 |
Approved |